此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Pragmatic Factorial Cluster Trial of Framing and Comparators for Audit and Feedback

2018年10月3日 更新者:Noah Ivers、Women's College Hospital

Pragmatic Factorial Cluster Trial of Framing and Comparators for Audit and Feedback Aiming to Address High Risk Prescribing in Nursing Homes in Ontario

Health Quality Ontario (HQO) is the provincial advisor on quality in health care. HQO currently conducts audit and feedback as a key quality improvement strategy. For example, it offers physicians working in long-term care homes with access to practice reports detailing rates of high-risk prescribing in comparison with others in Ontario and suggested change ideas. Research shows that providing this kind of feedback can lead to improvements in care. However, the size of these improvements depends how the feedback is presented. For instance, prior research suggests that how the results are 'framed' and what sort of benchmark the recipient is compared to may each affect how the physician will respond. This factorial trial tests each of these aspects of feedback design in the context of practice reports that nursing home physicians have already signed up to receive quarterly.

研究概览

研究类型

介入性

注册 (实际的)

285

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Ontario
      • Toronto、Ontario、加拿大、M5S1B2
        • Women's College Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 孩子
  • 成人
  • 年长者

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • a physician licensed by the College of Physicians and Surgeons of Ontario (CPSO);
  • practice in at least one LTC facility in Ontario;.
  • have voluntarily signed up to receive an HQO practice report

Exclusion Criteria:

  • n/a

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:卫生服务研究
  • 分配:随机化
  • 介入模型:阶乘赋值
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Arm 1, Positive Framing
All metrics in the audit and feedback practice reports presented with 'positive' framing, where the proportion of patients safe from risk (i.e., appropriate/desirable prescribing behaviours) is described.
实验性的:Arm 2, Negative Framing
All metrics in the audit and feedback practice reports presented with 'negative' framing, where the proportion of patients at risk (i.e., due to inappropriate/undesirable prescribing behaviours) is described.
实验性的:Arm 3, Top Quartile Comparator
All metrics in the audit and feedback practice reports presented and the physician-recipient's performance is compared against the 75th percentile for performance by physicians working in nursing homes in the province for each metric.
实验性的:Arm 4, Average Comparator
All metrics in the audit and feedback practice reports presented and the physician-recipient's performance is compared against the average performance by physicians working in nursing homes in the province for each metric.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
CNS-active medication prescribing
大体时间:6 months
monthly number of CNS-active medications per resident (antipsychotics, opioids, benzodiazepines or antidepressants (including TCAs and trazodone))
6 months

次要结果测量

结果测量
措施说明
大体时间
Benzodiazepine (or z-drug) prescribing
大体时间:6 months
days supplied (continuous)
6 months
Benzodiazepine (or z-drug) rates
大体时间:6 months
monthly proportion
6 months
Antipsychotic rates
大体时间:6 months
monthly proportion
6 months
Antipsychotic prescribing
大体时间:6 months
days supplied (continuous)
6 months
Mean Antipsychotic dose
大体时间:6 months
Dose equivalent of antipsychotic dispensed (continuous)
6 months
Mean Benzodiazepine dose
大体时间:6 months
Dose equivalent of benzodiazepine dispensed (continuous)
6 months
3+ CNS-active medications
大体时间:6 months
monthly proportion supplied three or more meds from the following classes: antipsychotics, opioids, benzodiazepines, or antidepressants (including TCAs and trazodone).
6 months
Anti-depressant prescribing
大体时间:6 months
days supplied (continuous) - balance measure
6 months
Anti-acid prescribing
大体时间:6 months
days supplied (continuous) - tracer outcome
6 months
Statin prescribing
大体时间:6 months
days supplied (continuous) - tracer outcome
6 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Noah M Ivers, MD PhD CCFP、Women's College Hospital - University of Toronto

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2016年12月6日

初级完成 (实际的)

2017年10月6日

研究完成 (实际的)

2018年7月1日

研究注册日期

首次提交

2016年11月29日

首先提交符合 QC 标准的

2016年11月29日

首次发布 (估计)

2016年12月2日

研究记录更新

最后更新发布 (实际的)

2018年10月5日

上次提交的符合 QC 标准的更新

2018年10月3日

最后验证

2018年10月1日

更多信息

与本研究相关的术语

其他研究编号

  • 2016-0122-E

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

IPD 计划说明

Analyses of outcomes use routine administrative database holdings.

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

Audit and Feedback的临床试验

3
订阅